COLL Price Targets and Analyst Ratings NASDAQ:COLL
COLL Forecast. What You Should Know.
COLL Historical Ratings and Targets
About Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.